Mindfulness-Based Cognitive Behavioral Program for People With Diabetes Mellitus
Effectiveness of A Mindfulness-Based Cognitive Behavioral Program on Quality of Life and Glycosylated Hemoglobin Control of People With Diabetes: A Randomized Controlled Trial in Damascus, Syria.
Studie Overzicht
Toestand
Interventie / Behandeling
Gedetailleerde beschrijving
Diabetes mellitus is a chronic condition that requires continuous self-management and may negatively affect psychological well-being, quality of life, and glycemic control. Psychological distress and difficulties in coping with diabetes may interfere with self-care behaviors and disease management.
This randomized controlled trial was conducted to evaluate the effectiveness of an integrated mindfulness-based cognitive behavioral program among adults with diabetes mellitus in Damascus, Syria. The intervention was designed to address psychological and behavioral factors that may affect diabetes self-management. It combined cognitive behavioral techniques, including psychoeducation, cognitive restructuring, behavioral activation, and coping strategies, with mindfulness exercises, relaxation techniques, emotional regulation, and home practice.
A total of 40 participants completed the study, with 20 participants allocated to the intervention group and 20 to the control group. Eligible adults with type 1 or type 2 diabetes were randomly assigned to either the intervention group or the control group. Participants in the intervention group received 14 weekly counseling sessions over approximately three months, with each session lasting approximately 90 minutes. The control group received routine diabetes care without an additional psychological intervention.
Quality of life was assessed using the World Health Organization Quality of Life-Brief Version (WHOQOL-BREF), which evaluates physical health, psychological health, social relationships, and environmental domains. Glycemic control was assessed using glycated hemoglobin (HbA1c) measured before and after the intervention. The Beck Depression Inventory (BDI) was used during screening to identify participants with mild to moderate depressive symptoms and determine eligibility; it was not used as an outcome measure.
The study aimed to determine whether the integrated mindfulness-based cognitive behavioral program could improve quality of life and glycemic control compared with routine diabetes care
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Damascus Governorate
-
Damascus, Damascus Governorate, Syrië
- Center for Strategic Studies and Health Training
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Adults aged 18-70 years.
- Diagnosis of type 1 or type 2 diabetes mellitus.
- Baseline HbA1c level greater than 6.5%.
- Mild to moderate depressive symptoms according to the Beck Depression - -Inventory (BDI).
- Ability to understand the study procedures and intervention instructions.
- Willingness to participate in all intervention sessions.
- Ability and willingness to provide written informed consent.
Exclusion Criteria:
- Severe psychiatric disorders requiring specialized psychiatric care.
- Acute medical conditions that could prevent participation in the intervention.
- Receiving regular psychotherapy or another similar psychological intervention.
- Inability to understand the intervention instructions.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Mindfulness-Based Cognitive Behavioral Intervention
Participants received a structured mindfulness-based cognitive behavioral program consisting of 14 weekly sessions over approximately three months, in addition to routine diabetes care.
|
Participants in the intervention group received a structured mindfulness-based cognitive behavioral program consisting of 14 weekly sessions delivered over approximately three months.
Each session lasted approximately 90 minutes, including a 15-minute break.
The program incorporated psychoeducation, cognitive restructuring, mindfulness exercises, behavioral activation, emotional regulation, relaxation techniques, coping strategies, and home practice assignments.
The intervention was delivered by qualified mental health professionals in addition to routine diabetes care.
|
|
Geen tussenkomst: Routine Diabetes Care (Control)
Participants received routine diabetes care without any additional psychological or behavioral intervention during the study period.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in Glycated Hemoglobin (HbA1c) Level
Tijdsspanne: Baseline and 3 months (post-intervention).
|
Change in HbA1c level from baseline to immediately after completion of the intervention.
|
Baseline and 3 months (post-intervention).
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Within-group change in Quality of Life Measured by the World Health Organization Quality of Life-BREF (WHOQOL-BREF) Questionnaire
Tijdsspanne: Baseline and 3 months (evaluated in the intervention arm).
|
Change in quality of life from baseline to 3 months (post-intervention), measured using the World Health Organization Quality of Life-BREF (WHOQOL-BREF) questionnaire within the intervention group.
The questionnaire assesses four primary domains: Physical Health, Psychological Health, Social Relationships, and Environment, with domain scores ranging from 4 to 20, where higher scores indicate better quality of life.
An overall quality of life index is also calculated on a scale of 0 to 100, with higher values reflecting superior general quality of life.
|
Baseline and 3 months (evaluated in the intervention arm).
|
Medewerkers en onderzoekers
Onderzoekers
- Hoofdonderzoeker: ZaynALsham M AlQatrangi, BPharm, MPH, Center for Strategic Studies and Health Training
Publicaties en nuttige links
Algemene publicaties
- Winkley K, Upsher R, Stahl D, Pollard D, Brennan A, Heller SR, Ismail K. Psychological interventions to improve glycemic control in adults with type 2 diabetes: a systematic review and meta-analysis. BMJ Open Diabetes Res Care. 2020 Apr;8(1):e001150. doi: 10.1136/bmjdrc-2019-001150.
- Newby J, Robins L, Wilhelm K, Smith J, Fletcher T, Gillis I, Ma T, Finch A, Campbell L, Andrews G. Web-Based Cognitive Behavior Therapy for Depression in People With Diabetes Mellitus: A Randomized Controlled Trial. J Med Internet Res. 2017 May 15;19(5):e157. doi: 10.2196/jmir.7274.
- Zarifsanaiey N, Jamalian K, Bazrafcan L, Keshavarzy F, Shahraki HR. The effects of mindfulness training on the level of happiness and blood sugar in diabetes patients. J Diabetes Metab Disord. 2020 Mar 2;19(1):311-317. doi: 10.1007/s40200-020-00510-7. eCollection 2020 Jun.
- Yang X, Li Z, Sun J. Effects of Cognitive Behavioral Therapy-Based Intervention on Improving Glycaemic, Psychological, and Physiological Outcomes in Adult Patients With Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials. Front Psychiatry. 2020 Jul 28;11:711. doi: 10.3389/fpsyt.2020.00711. eCollection 2020.
- Ni YX, Ma L, Li JP. Effects of mindfulness-based intervention on glycemic control and psychological outcomes in people with diabetes: A systematic review and meta-analysis. J Diabetes Investig. 2021 Jun;12(6):1092-1103. doi: 10.1111/jdi.13439. Epub 2020 Nov 22.
- DiNardo MM, Greco C, Phares AD, Beyer NM, Youk AO, Obrosky DS, Morone NE, Owen JE, Saba SK, Suss SJ, Siminerio L. Effects of an integrated mindfulness intervention for veterans with diabetes distress: a randomized controlled trial. BMJ Open Diabetes Res Care. 2022 Mar;10(2):e002631. doi: 10.1136/bmjdrc-2021-002631.
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- CSSHT-MBCB-001
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .